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Abstract
Background: As a novel cancer diagnostic paradigm, mass spectroscopic serum proteomic
pattern diagnostics was reported superior to the conventional serologic cancer biomarkers.
However, its clinical use is not fully validated yet. An important factor to prevent this young
technology to become a mainstream cancer diagnostic paradigm is that robustly identifying cancer
molecular patterns from high-dimensional protein expression data is still a challenge in machine
learning and oncology research. As a well-established dimension reduction technique, PCA is
widely integrated in pattern recognition analysis to discover cancer molecular patterns. However,
its global feature selection mechanism prevents it from capturing local features. This may lead to
difficulty in achieving high-performance proteomic pattern discovery, because only features
interpreting global data behavior are used to train a learning machine.
Methods: In this study, we develop a nonnegative principal component analysis algorithm and
present a nonnegative principal component analysis based support vector machine algorithm with
sparse coding to conduct a high-performance proteomic pattern classification. Moreover, we also
propose a nonnegative principal component analysis based filter-wrapper biomarker capturing
algorithm for mass spectral serum profiles.
Results: We demonstrate the superiority of the proposed algorithm by comparison with six peer
algorithms on four benchmark datasets. Moreover, we illustrate that nonnegative principal
component analysis can be effectively used to capture meaningful biomarkers.
Conclusion: Our analysis suggests that nonnegative principal component analysis effectively
conduct local feature selection for mass spectral profiles and contribute to improving sensitivities
and specificities in the following classification, and meaningful biomarker discovery.
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With the rapid advances in proteomics, mass spectro-
scopic serum proteomic pattern diagnostics has been
appearing as a revolutionary cancer diagnostic paradigm.
However, this technology still remains as an important
field in clinical research study rather than a clinical
routine testing [1]. There are many issues to be resolved
to realize the routine clinical testing. Asides from the
issues like data reproducibility and quality control [2],
one essential issue prevents it going beyond clinical
research study sets is that there is no robust supervised
learning algorithm to classify proteomic patterns with
high sensitivities and specificities. Although there is an
urgent need to predict cancer molecular patterns with
high accuracies to support clinical decisions, it is still a
challenge for oncologists and computational biologists
to achieve a high-performance classification due to the
special characteristics of mass spectral data.
The mass spectral data has large or even huge dimen-
sionalities. It can be represented by a n × m matrix, each
row of which represents the ion intensity values of all
biological samples in investigation at a mass charge ratio
(m/z); each column of which represents the ion intensity
values of a single biological sample at different m/z
values. Each raw data can be called a pseudo-gene since it
is similar to a gene in a gene expression dataset.
Generally, the total number of m/z ratios is in the
order of 10
4~10
6 and the total number of biological
samples is on the magnitude of hundreds, i.e., the
number of variables is much greater than the number of
biological samples. Although there are a large number of
m/z ratios in a mass spectral profile, only a small
number of them have meaningful contributions to the
data variations.
Many feature selection algorithms are employed to
reduce the protein expression data dimensions, remove
noise, and extract meaningful features before further
classification or clustering. These algorithms include
two-sample t-tests, principal component analysis (PCA),
independent component analysis (ICA), nonnegative
matrix factorization (NMF) and their different variants
[3-5]. PCA may be the most employed among them for
its simplicity. It projects data in an orthogonal subspace
generated by the eigenvectors of the data covariance
matrix. The maximum variance direction-based subspace
spanning guarantees the least information loss in the
feature selection. However, as a holistic feature selection
algorithm, PCA can only capture global features instead
of local features [6]. The global and local features
contribute to the global and local characteristics of
data that are responsible for interpreting the global and
local behavior of data respectively. The standard PCA by
nature can not extract local features. This not only leads
to difficulty in interpreting each principal component
(PC) intuitively, but also causes some difficulty in
achieving high-performance proteomic pattern discov-
ery, because only the features interpreting global
behavior of data are used to train a learning machine
(e.g., a support vector machine (SVM) [7]). Since
redundant global features may be involved in training,
it will decrease the generalization of the learning
machine and increase the risk of misclassifications or
over-fitting. Moreover, the global data characteristics of a
cancer or normal pattern are generally similar because
they follow the same protein profiling mechanism. This
can be easily verified by the direct visualization of mass
spectral profiles. In other words, the local data char-
acteristics play a key role in distinguishing cancer and
normal proteomic patterns.
One reason for the holistic mechanism of PCA is that its
data representation is not ‘purely-additive’. The linear
combination to calculate each PC contains both positive
and negative weights. The positive and negative weights
are likely to partially cancel each other in the linear
combination. In fact, weights representing contributions
from local features are more likely to be cancelled out
because of their frequencies. This partial cancellation
may directly lead to missing captures of local features for
each loading vector. Another reason for the global nature
of PCA is that it lacks some level sparse representation.
Each loading vector receives contributions from all input
variables in the linear combination. Changes in one
variable will inevitably affect all loading vectors globally.
Imposing nonnegativity constraints on PCA can remove
the partial cancellations in the linear combinations and
make data representation consist of only additive
components, i.e., restrict all entries of the input data
and each PC as nonnegative items. Adding nonnegativity
on PCA is also motivated by proteomic pattern discovery
itself. The mass spectral profiling data is generally
represented as a positive matrix naturally. It is reason-
able to require its corresponding dimension-reduction
data to be positive or at least nonnegative to maintain
data locality in the feature selection for the sake of
pattern discovery. Furthermore, imposing nonnegativity
constraints on PCA also leads to the sparse representa-
tion of loading vectors.
In this study, we present a nonnegative principal
component analysis (NPCA) algorithm and propose a
nonnegative principal component analysis based
support vector machine algorithm (NPCA-SVM) for
high-performance proteomic pattern discovery. We
demonstrate its algorithm superiority by comparing it
with six peer classification algorithms on four benchmark
mass spectral serum datasets. In addition, we present an
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negative principal component analysis.
This work is evolved from our previous naïve work on
protein expression classification [8]. However, our
current work has the following major advances/differ-
ences compared to the previous work. 1. A robust
gradient learning scheme is developed for nonnegative
principal component analysis and a complete nonnega-
tive principal component analysis based support vector
machine algorithm is proposed rigorously. 2. The
optimal orthogonal parameter selection method is
discussed and an empirical parameter choice approach
is given. In addition, we also give a method to set the
sparseness control parameter. 3. In addition to including
previous three datasets and regenerating all simulation
results, we include a new dataset: colorectal data in the
experiment. Moreover, a new comparison algorithm:
ICA-SVM is included in the simulation. 4. A nonnegative
component principal analysis based filter-wrapper bio-
marker discovery by employing Bayesian t-test based
filtering is proposed and its biomarker discovery results
for the ovarian and colorectal data are analyzed and
visualized. 5. The major global feature selection methods
are presented and the two key concepts: global and local
features are defined and their impacts in classifications
are discussed. 6. We dropped all figures, and tables, and
redundant results (e.g. over-fitting analysis about com-
parison algorithms) from the previous work.
Methods
Nonnegative principal component analysis is an exten-
sion of the classic PCA algorithm by imposing it with
nonnegativity constraints to capture data locality in the
feature selection. Let X =( x1, x2,... xn), xi Œ R
d be a zero
mean dataset, the nonnegative PCA can be formulated as
a constrained optimization problem to find maximum
variance directions under nonnegative constraints as
follows,
max ( , )
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where U =[ u1, u2,...uk], k ≤ d is a set of nonnegative PCs.
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The principal component matrix U is a near-orthonor-
mal nonnegative matrix, i.e., U
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The nonnegative principal component analysis complex-
ity is O(dkn × N), where N is the total iterations needed to
meetthealgorithmterminationthreshold||∇UJ(t)||≤10
-4
in the implementation. Other authors also proposed a
similar approach to solve a nonlinear optimization
problem induced by a nonnegative sparse PCA [9],
where two penalty parameters were employed to control
the orthonormality and sparseness of the PC matrix.
However, an additional sparseness control parameter will
increase the risk of algorithmic convergence difficulty
with the increasing of the parameter values [10].
We propose a nonnegative principal component
analysis based classification algorithm to achieve the
high-performance proteomic pattern prediction. The
algorithm employs nonnegative principal component
analysis to obtain the nonnegative representation of each
sample in a low-dimensional, purely-additive subspace
spanned by meta-variables. A meta-variable is a linear
combination of the intensity values of the pseudo-genes
in a mass spectral profile. The nonnegative representa-
tion for each sample is denoted as a meta-sample, which
is the locality-preserved prototype of the original
biological sample with low dimensionalities. Then, a
classification algorithm, which is chosen as a support
vector machine algorithm (SVM) [7] in this study, is
applied to the meta-samples to gain classification
information. Given a protein expression training dataset
consisting of d biological samples across n pseudo-genes
and their label information: {,} xc ii i
d
=1,w h e r eX =[ x1,
x2...xd]
T xi Œ R
n and c =[ c1, c2...cd]
T, ci Œ {-1, 1},
the NPCA-SVM algorithm finds the meta-samples
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d×k, k ≤ d ≪ n, by the described
steepest descent method. Then, an optimal separating
hyperplane Oh: w
Tu + b =0i nR
d is computed to attain
the maximum margin between the ‘-1’ and ‘1’ types of
the meta-samples. This is equivalent to solving the
following quadratic programming problem in R
d,
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Given an unknown type sample x’ Œ R
n,t h eN P C A - S V M
learning machine employs the following decision rule to
determine its class type: fx s i g n c kuu b ii i
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d
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where ui, u’ Œ R
d are the meta-samples of samples xi, x’
computed from nonnegative principal component analysis
respectively. The vector a =[ a1, a2... ad] ≥ 0 is the solution
of the dual problem of the QP in Eq. (4) and k(ui￿u’)i sa
kernel function for the support vector machine, which
maps these meta-samples into a same-dimensional or
high-dimensional feature space. We only focus on the
linear and ‘rbf’ kernels for their popularity [7].
We employ a sparse-coding approach to improve
the sparseness for each meta-sample. The sparseness
of a nonnegative vector v =[ v1, v2...vn]
T, vi ≥ 0,
i =1 ,2 . . . n, is defined as a ratio between 0 and
1: δv nv v n =− − (/ ) / ( )
12 1 according to the
relationship of two norms [6]. A large sparseness δv
indicates less number of positive entries in the vector v
Extreme cases δv =1o rδv = 0 indicate that there is only
one entry or all entries are equal in v respectively. The
sparse coding of a meta-sample ui
Tk ∈
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k ≤ d ≪ n seeks to find a nonnegative vector v Œ R
1×k
such that vuvu i
T
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specified sparseness value. In other words, for each
loading vectorui
T in the nonnegative PC matrix, the
nearest nonnegative vector v on behalf of L1 and L2
distances is found to achieve a specified sparseness δv.I t
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point between a hyperplane π1
11
: vu j
j
k
ij
j
k
== ∑∑ = and a
hypersphere π 2
11
: vu j
j
k
ij
j
k
== ∑∑ = such that the sparseness
degree δvi
T ku k =− − () / ( )
1
1 .S i n c et h et r a d i t i o n a l
approach to find the optimal a is computationally
expensive [10], we select a ∝ d in practice because of ||
U
TU|| = d
2 in the extreme case where U is the identity
matrix, if there is no further sparse coding applied to
loading vectors. Otherwise, we select α ∝ d .A l s o
because data sparseness is a by-product of the non-
negativity constraints in Eq. (1), we usually select the
sparseness degree for each nonnegative principal com-
ponent as δv ≤ 0.5.
We implement the NPCA-SVM algorithm under the
100 trials of 50% holdout cross validations (HOCV),
i.e., 100 sets of training and testing data are generated
randomly for each dataset. The final classification rate,
sensitivity and specificity are the average values of these
measures among the 100 trials of classifications. To
improve computing efficiency, the PC matrix U in the
nonnegativeprincipalcomponentanalysisiscachedfrom
the previous trial and used as the initial point to compute
the next principal component matrix in the computation.
Results
Four serum proteomic datasets: ovarian, ovarian-qaqc
(quality assurance/quality control), liver and colorectal
are included in this study [11-13], which are generated
from three different profiling technologies. Table 1
provides the detailed information about the datasets.
We conducted the following preprocessing for each
dataset: baseline correction, smoothing, normalization,
peak identification and peak calibration by using Matlab
bioinformatics toolbox 3.3. In addition, we applied the
standard two-sample t-test to select 3780, 2500, 3000
and 1000 most significant pseudo-genes for the ovarian,
ovarian-qaqc, liver, and colorectal data respectively
before further classifications. The goal of this basic
feature selection is to select approximately 10 × d most
significant features for each input dataset X Œ R
d×n before
classification. We compared the nonnegative principal
component analysis based support vector machine
algorithm with the six peers: k-NN, SVM, PCA-SVM,
NMF-SVM, ICA-SVM and PCA-LDA algorithms in terms
of average classification rates, sensitivities, and specifi-
cities under 100 trials of 50% HOCV. Detailed informa-
tion about the algorithms: LDA, NMF and ICA
algorithms can be found in [14,6,5]. In the NPCA-SVM
algorithm, we set the orthonormal control a = 10, the
sparseness for each loading vector δv = 0.20, and k = d -1
in the NPCA feature selection due to n ≪ d.
We showed the average performance of the seven
algorithms in terms of average classification rates,
sensitivities, specificities, and their corresponding stan-
dard deviations in Table 2. We did not include
performance of the SVM, PCA-SVM, ICA-SVM and
NMF-SVM algorithms under the ‘rbf’ kernel, because
the first three encountered over-fitting and the last had
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kernel. We had the following observations from these
results. 1) The NPCA-SVM algorithm achieved obviously
leading advantages over the others. Its average specifi-
cities for the two ovarian cancer datasets reached 99%+
that was the population screening requirement ratio in
the clinical diagnostics. It also achieved 98.35% average
specificity for the colorectal data and 98.35% average
sensitivity for the liver data. It was the only algorithm
among the seven algorithms that achieved consistently
leading performances for all datasets. 2) There was no
over-fitting associated with the NPCA-SVM algorithm
under the ‘rbf’ kernel. Alternatively, it achieved excep-
tional sensitivities and specificities under this kernel.
3) The conventional feature selection algorithms PCA,
NMF and ICA generally did not contribute to the
improvements of SVM classifications.
Figure 1 compares the average classification rates,
sensitivities, specificities and negative target prediction
ratios of the NPCA-SVM algorithms with those of the
other four algorithms: ICA-SVM, PCA-SVM, SVM and
PCA-LDA. It was obvious that the NPCA-SVM algorithm
with sparse coding under the ‘rbf’ and ‘linear’ kernels
demonstrated superior or comparable performance
compared with the other four algorithms.
Biomarker discovery by nonnegative principal
component analysis
In this section, we presented a nonnegative principal
component analysis based filter-wrapper biomarker
capturing algorithm. The Bayesian two-sample t-test
[15] and nonnegative principal component analysis
functioned as filters and a SVM classifier worked as a
wrapper in this algorithm. Unlike other peak-selection
based biomarker capturing methods [12,13], our algo-
rithm could identify which pseudo-genes were more
effective in predicting cancer patterns. The NPCA-based
biomarker discovery algorithm can be described as
follows. For an input mass spectral data X Œ R
n×m with
m pseudo-genes and n biological samples, we first filter a
potential biomarker set Sb by conducting the two-sample
Bayesian t-test, which is a novel approach to evaluate
each pseudo-gene according to their differentially
expressed levels. The potential biomarker set Sb consists
of significantly differentially-expressed pseudo-genes.
For each dataset, we select at least the top 1% pseudo-
genes with the smallest Bayesian factors, i.e., |Sb|=Èm ×
0.01˘ to construct Sb. Then, nonnegative principal
component analysis (NPCA) is employed to decompose
the input data: X
T~PU
T For each pseudo-gene, a
coefficient τ is used to rank its contribution to all PCs.
For example, the coefficient for the i
th pseudo-gene is
calculated as the weighted sum of the i
th row in the
nonnegative P matrix: τ ij i j
j
PC
wP =
= ∑ log
#
1
,w h e r e
Table 1: Four mass spectral serum profiles
Dataset Technology #m/z #Samples
Ovarian SELDI-TOF low resolution 15142 91 controls + 162 cancers
Ovarian-qaqc SELDI-TOF high resolution 15000 95 controls + 121 cancers
Liver SELDI-QqTOF high resolution 6107 176 controls + 181 cancers
Colorectal MADLI-TOF high resolution 16331 48 controls + 64 cancers
Table 2: Comparisons of the seven algorithms
Average
Classifying rate
(%)
Average
Sensitivity
(%)
Average
Specificity
(%)
Ovarian
npca-svm-linear 98.94 ± 00.65 98.35 ± 01.03 99.98 ± 00.24
npca-svm-rbf 99.79 ± 00.35 100.0 ± 00.00 99.42 ± 00.99
svm-linear 99.50 ± 00.83 100.0 ± 00.00 98.63 ± 02.21
pca-svm-linear 99.96 ± 00.26 99.98 ± 00.17 99.93 ± 00.51
nmf-svm-linear 97.41 ± 00.94 99.91 ± 00.31 92.92 ± 02.50
knn 96.53 ± 01.57 99.28 ± 01.34 91.67 ± 03.67
pca-lda 99.67 ± 00.87 99.93 ± 00.38 99.21 ± 02.00
ica-svm-linear 99.99 ± 00.08 99.99 ± 00.12 100.0 ± 00.00
Ovarian-qaqc
npca-svm-linear 98.70 ± 00.89 98.01 ± 01.94 99.27 ± 00.90
npca-svm-rbf 98.91 ± 00.98 98.11 ± 02.25 99.57 ± 00.82
svm-linear 96.57 ± 01.99 96.16 ± 03.52 96.97 ± 02.19
pca-svm-linear 97.12 ± 01.17 97.14 ± 02.16 97.94 ± 01.57
nmf-svm-linear 88.69 ± 03.47 92.02 ± 05.01 86.24 ± 05.67
knn 90.87 ± 02.92 89.99 ± 04.68 91.82 ± 04.43
pca-lda 97.69 ± 00.65 98.81 ± 01.68 96.99 ± 00.03
ica-svm-linear 97.56 ± 01.45 97.80 ± 02.46 97.41 ± 01.77
Liver
npca-svm-linear 96.02 ± 01.35 97.68 ± 01.71 94.40 ± 02.22
npca-svm-rbf 97.25 ± 01.30 98.35 ± 01.67 96.20 ± 02.01
svm-linear 91.78 ± 02.27 92.57 ± 03.84 91.04 ± 03.76
pca-svm-linear 90.21 ± 01.99 90.96 ± 03.69 89.57 ± 03.56
nmf-svm-linear 77.76 ± 02.48 84.58 ± 05.14 71.30 ± 05.12
knn 76.48 ± 02.20 72.27 ± 04.60 80.80 ± 04.57
pca-lda 90.08 ± 02.13 91.39 ± 03.53 88.87 ± 03.95
ica-svm-linear 86.61 ± 02.87 87.78 ± 04.55 86.50 ± 04.86
Colorectal
npca-svm-linear 98.14 ± 01.27 97.93 ± 02.32 98.35 ± 02.00
npca-svm-rbf 97.15 ± 01.07 95.81 ± 02.78 98.18 ± 02.22
svm-linear 96.55 ± 01.87 94.35 ± 03.47 98.26 ± 02.16
pca-svm-linear 93.21 ± 03.38 92.59 ± 04.68 93.89 ± 05.56
nmf-svm-linear 94.73 ± 03.09 92.71 ± 06.14 96.49 ± 03.45
knn 95.05 ± 03.17 96.17 ± 02.91 94.28 ± 05.33
pca-lda 94.05 ± 02.78 94.16 ± 03.74 94.01 ± 04.12
ica-svm-linear 96.04 ± 02.02 94.38 ± 03.66 97.39 ± 02.97
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is the ratio of variance explained in the
j
th PC among the total data variance. A large coefficient
value of a pseudo-gene indicates it has significant
contributions to the PCs.
Each pseudo-gene in Sb is used to train a SVM classifier
under the leave-one-out cross validation (LOOCV). The
first biomarker g1 is selected as the pseudo-gene with the
highest accuracy. If there is more than one candidate, the
pseudo-gene with the largest coefficient in NPCA-
ranking will be selected. The potential biomarker set is
updated by removing the selected biomarker, i.e, Sb = Sb -
{g1}. The second biomarker g2 is selected from the
current Sb such that the SVM classifier reaches its
maximum classification rate for the combination of g1
and g2. If there is more than one candidate, the pseudo-
gene with the largest coefficient in the NPCA-ranking
will be chosen as g2. Similarly, Sb is updated as Sb = Sb -
{g2}. Such a proceeding continues until the SVM
classifier achieves the maximum classification accuracy
with the fewest biomarkers.
We applied the nonnegative principal component
analysis based biomarker capturing algorithm to the
colorectal dataset. The potential biomarker set Sb was
initialized by 200 pseudo-genes with the smallest Bayes
factors. The alpha value in NPCA was set as a =1 0t o
maintain consistency with the previous classification
setting. Table 3 shows the information about three
biomarkers discovered for the colorectal data. The total
SVM accuracy under the three biomarkers was 98.21%
and the corresponding sensitivity and specificity were
95.83% and 100% respectively, which was better than
Figure 1
Comparison on the five algorithm performance. Comparison on the five algorithm performance on four datasets: ‘O1’
(ovarian), ‘O2’ (ovarian-qaqc), ‘L’ (liver), and ‘C’ (colorectal). The NPCA-SVM algorithm demonstrated leading performance over
the other four algorithms.
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interesting that these biomarkers were not peaks with
very large intensity values. The similar results can also be
obtained by running the biomarker capture algorithms
under the ‘rbf’ kernel. The final SVM accuracy also
reached 98.21% with three biomarkers at 970.0379,
973.1689 and 997.5336 Da. Interestingly, the biomar-
kers from different kernels not only shared a same
pseudo-gene at 997.5336 Da, but also demonstrated a
spatial coherence, i.e., they were neighbors close or very
close to each other among 16331 m/z ratios in the data.
It indicated that m/z ratios in the downstream interval
960-1030 Da may be more sensitive in discovering
cancer patterns than others. Figure 2 visualizes all
samples of the colorectal data by using the three
biomarkers found under the linear kernel. It is clear
that the 112 samples are partitioned into two groups: 64
cancers and 48 controls, and the two types of samples
showed significantly different mean and variance values.
Similarly, we applied this algorithm to the ovarian data
and obtained 100% predication accuracy (sensitivity:
100%, specificity: 100%) from four biomarkers at m/z
ratios: (0.452124, 0.000096, 0.530561, 1.276201) under
the linear kernel. Moreover, The SVM classifier also
achieved 99.60% accuracy, 100% sensitivity, and
98.90% specificity under the ‘rbf’ kernel from three
biomarkers at m/z ratios: (0.464762, 0.000096,
0.517053). Also similar to the previous case, the
biomarkers discovered under different kernels illustrated
spatial proximityandsharedsame pseudo-genes.Figure 3
visualizes all 253 samples by using the three biomarkers
obtained from the ‘rbf’ kernel. It was also obviously that
cancer and control samples were separated clearly by the
three biomarkers.
Discussion
Although nonnegative principal component analysis has
overcome the global nature of the standard PCA
algorithm, and contributed to the high-performance
proteomic pattern prediction and effective biomarker
capture, it is an expensive algorithm with a high
complexity O(d
2n × N) compared to the classic PCA
algorithm O(d
3) for an input data X Œ R
d×n, d ≪ n.I t
may require some basic feature selection preprocessing
such as the two-sample t-test to avoid a large computing
burden for a high-dimensional dataset. On the other
hand, since the final PC matrix in nonnegative principal
component analysis is computed through a fixed instead
of an optimal step size in the iteration, it may miss some
local optimal solutions and lead to potential conver-
gence problems. In the following work, we plan to
improve nonnegative principal component analysis
Table 3: Biomarkers captured for the colorectal data
m/z Bayes factor npca-coefficient SVM ratio (%)
969.1849 7.7881e-031 -1.1205 0.9643
997.5336 1.4236e-026 -1.1571 0.9018
1016.389 7.6644e-013 1.2773 0.8152
Figure 2
Visualization of the colorectal samples by using three biomarkers. The 48 control and 64 cancer samples are
visualized by using the three biomarkers. Two types of samples demonstrated significantly different means and variations.
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the wavelet based multi-resolution approach to over-
come the high algorithm complexity in NPCA. A wavelet
transform is first employed to decompose an input data
into a multi-resolution form. The nonnegative principal
component analysis (NPCA) is then employed to extract
the local data features from the fine level wavelet
transform coefficients, which are relatively low dimen-
sional data compared with the input protein expression
data. (2) We will employ a projected-gradient algorithm
[10] with a dynamic step size to improve the non-
negative principal component analysis algorithm con-
vergence. As a local feature selection algorithm,
nonnegative principal component analysis can be
integrated with other state-of-the-art classification and
clustering algorithms to develop a family of statistical
learning algorithms. For instance, we are interested in
combining it with the linear programming SVM algo-
rithm [7] to further explore its potentials in proteomic
data pattern prediction. Moreover, we will continue to
investigate the applications of the NPCA-SVM algo-
rithms in SNP, CGH array data analysis, and other
related topics in future work, in addition to integrating
the sparse-coding in our previous NPCA-SVM algorithm
developed for gene expression profiles [16].
Conclusion
In this work, we developed a novel feature selection
algorithm, nonnegative principal component analysis,
and proposed the nonnegative principal component
analysis based support vector machine algorithm with
sparse coding for high performance proteomic pattern
discovery. We demonstrated the superiority of this
algorithm by comparing it with other six peer algorithms
on four proteomic datasets. In addition, we have
designed a NPCA-based filter-wrapper biomarker captur-
ing algorithm and applied it to effectively capture
meaningful biomarkers for the colorectal and ovarian
data. Our analysis suggests that nonnegative principal
component analysis has advantages over the conven-
tional feature selection algorithm such as PCA, ICA, and
NMF in local feature selections. Although its algorithmic
complexity is higher than that of widely used PCA
algorithm, its nature of local feature selection contri-
butes to the high-performance serum proteomic pattern
classification and meaningful biomarker discovery.
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